Institute for Life Sciences and Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Building 85, Southampton, SO17 1BJ, UK.
Institute for Life Sciences and Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Building 85, Southampton, SO17 1BJ, UK.
Curr Opin Immunol. 2021 Jun;70:138-143. doi: 10.1016/j.coi.2021.06.016. Epub 2021 Jul 12.
Major Histocompatibility Complex class I (MHC I) molecules are highly polymorphic, with allotypes differing in peptide binding preferences, and in their dependence upon tapasin for optimal peptide selection. The tapasin dependence of MHC allotypes is inversely correlated with their self-editing ability, and underpinned by conformational plasticity. Recently, TAPBPR has been shown to enhance MHC I assembly via a chaperone-like function, and by editing the peptide repertoire of some MHC I allotypes. Structural analysis has shown TAPBPR binding changes the conformation and dynamics of MHC I, with MHC protein dynamics likely to determine the prevailing TAPBPR function: generically enhancing MHC I assembly by stabilising highly dynamic peptide-empty MHC I; and by editing the peptide repertoire of highly dynamic MHC I allotypes.
主要组织相容性复合体 I 类 (MHC I) 分子高度多态性,同种异型在肽结合偏好上有所不同,并且依赖 tapasin 进行最佳肽选择。MHC 同种异型对 tapasin 的依赖性与它们的自我编辑能力成反比,并受构象可塑性的支持。最近,TAPBPR 已被证明通过伴侣样功能增强 MHC I 的组装,并通过编辑某些 MHC I 同种异型的肽库。结构分析表明,TAPBPR 结合改变了 MHC I 的构象和动力学,MHC 蛋白动力学可能决定 TAPBPR 的主要功能:通过稳定高度动态的肽空 MHC I 来普遍增强 MHC I 的组装;并通过编辑高度动态 MHC I 同种异型的肽库。